Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bedrocan Cannabis Corp. V.BED

Healthcare Biotechnology


TSXV:BED - Post by User

Bedrocan Cannabis Corp. > Cool with me
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(902)
•••
Comment by CommonCentsforDollarson May 07, 2015 3:32pm
94 Views
Post# 23705632

RE:RE:RE:RE:Cool with me

RE:RE:RE:RE:Cool with meI guess we all see things differently, that question was one of my reasons for selling my position of bed.

Do you think they have 20,000 "retained patients" oversea's, or 20,000 patients have tried it at one time or another over the last 13 years?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities